Literature DB >> 22284143

Quality of life measures for acne patients.

Lauren E Barnes1, Michelle M Levender, Alan B Fleischer, Steven R Feldman.   

Abstract

Acne vulgaris affects most adolescents and two-thirds of adults and is associated with substantial psychosocial burden. Health-related quality of life (HRQOL) for patients with acne is an important factor of patient care, and several dermatologic and acne-specific measures have been created to assist in acne research, management, and care. This review describes several skin disease and acne-specific HRQOL measures and their applications in clinical care or research. The ideal HRQOL measure for the management of patients with acne is a concise questionnaire that places minimal burden on respondents and allows physicians to track improvement in HRQOL with successful treatment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 22284143     DOI： 10.1016/j.det.2011.11.001

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  12 in total

1.  Impact of facial and truncal acne on quality of life: A multi-country population-based survey.

Authors:  Jerry Tan; Stefan Beissert; Fran Cook-Bolden; Rajeev Chavda; Julie Harper; Adelaide Hebert; Edward Lain; Alison Layton; Marco Rocha; Jonathan Weiss; Brigitte Dréno
Journal:  JAAD Int       Date:  2021-04-27

2.  Understanding the burden of adult female acne.

Authors:  Emil A Tanghetti; Ariane K Kawata; Selena R Daniels; Karen Yeomans; Caroline T Burk; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

3.  Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne.

Authors:  Valerie D Callender; Andrew F Alexis; Selena R Daniels; Ariane K Kawata; Caroline T Burk; Teresa K Wilcox; Susan C Taylor
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

4.  Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review.

Authors:  Hayley Smith; Alison M Layton; Diane Thiboutot; Abbey Smith; Heather Whitehouse; Waseem Ghumra; Meenakshi Verma; Jerry Tan; Georgina Jones; Kathryn Gilliland; Megha Patel; Elaine Otchere; Anne Eady
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

5.  Acne vulgaris and quality of life among young adults in South India.

Authors:  Priya Cinna T Durai; Dhanya G Nair
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

6.  Assessment of Life Quality Index Among Patients with Acne Vulgaris in a Suburban Population.

Authors:  Neirita Hazarika; Radha K Rajaprabha
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

7.  Putative Genes and Pathways Involved in the Acne Treatment of Isotretinoin via Microarray Data Analyses.

Authors:  Biao Chen; Peishan Li; Jun Li; Jinping Chen
Journal:  Biomed Res Int       Date:  2020-06-29       Impact factor: 3.411

8.  A randomized, double-blind, placebo-controlled study of a novel pantothenic Acid-based dietary supplement in subjects with mild to moderate facial acne.

Authors:  Michael Yang; Betsy Moclair; Virgil Hatcher; Jed Kaminetsky; Maria Mekas; Anne Chapas; Jillian Capodice
Journal:  Dermatol Ther (Heidelb)       Date:  2014-05-16

9.  Efficacy of photodynamic therapy combined with minocycline for treatment of moderate to severe facial acne vulgaris and influence on quality of life.

Authors:  Xinghua Xu; Yi Zheng; Zigang Zhao; Xin Zhang; Pengxiang Liu; Chengxin Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Pilot study for the evaluation and adaptation of a Four Item-Acne-Scar Risk Assessment Tool (4-ASRAT): a resource to estimate the risk of acne-induced scars.

Authors:  Jorge Estrella Porter; Mikaela Camacho; María Isabel Viteri; Katherine Aguilar; Drifa Belhadi; Vincenzo Bettoli; Anita Del Rocío Buestán; Brigitte Dréno; Pablo Endara; Alison Layton; Nelly Machado; Rosa Mateus; Jerry Tan; Enrique Terán; Paola Yépez; Jonathan Guillemot
Journal:  F1000Res       Date:  2020-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.